Open | $32.660 |
Close | $32.170 |
Volume / Avg. | 685.921K / 1.050M |
Day Range | 32.090 - 32.665 |
52 Wk Range | 23.330 - 36.700 |
Market Cap | $3.664B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 46 |
Short Interest | 11.66% |
Days to Cover | 12.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Evolent Health (NYSE: EVH) through any online brokerage.
Other companies in Evolent Health’s space includes: MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX), Trxade Health (NASDAQ:MEDS) and Definitive Healthcare (NASDAQ:DH).
The latest price target for Evolent Health (NYSE: EVH) was reported by JP Morgan on Friday, March 15, 2024. The analyst firm set a price target for 52.00 expecting EVH to rise to within 12 months (a possible 61.64% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Evolent Health (NYSE: EVH) is $32.17 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Evolent Health.
Evolent Health’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Evolent Health.
Evolent Health is in the Health Care sector and Health Care Technology industry. They are listed on the NYSE.